Howard Capital Management Group, LLC Organicell Regenerative Medicine, Inc. Transaction History
Howard Capital Management Group, LLC
- $1.42 Billion
- Q3 2024
About Organicell Regenerative Medicine, Inc.
- Ticker OCEL
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,476,130,048
- Market Cap $1.7B
- Description
- Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Its leading product candidate is Zofin, an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs...